Thermal ablation for subcutaneously implanted hepatocellular carcinoma in mice
Author:
Affiliation:

Clc Number:

R735.7

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective: To establish a mice model of liver cancer suitable for microwave ablation. Methods: C57BL/6J mice were randomly divided into 4 groups (n=10 in each group) and subcutaneously injected with Hepa1-6 cells of different numbers (5×105, 1×106, 2×106 and 5×106) respectively, and then the tumor formation rates in the 4 groups were compared. Next, the ideal cell number for tumor formation was selected to establish the mouse models once again. When mean tumor diameter reached 8–10 mm, the tumor-bearing mice were randomly divided into 4 groups (n=10 in each group) to undergo microwave thermal tumor ablation. The temperature at the edge of the tumor was maintained at 60, 55, 50, and 45℃ respectively, and the ablation time was 3 min. The complete ablation rate and pathological changes of tumor among the 4 groups were compared. Results: The group with 2×106 Hepa1-6 subcutaneous injection had a high tumor formation rate and was suitable for ablation. Except for 60℃ ablation group, in other 3 groups, the 55℃ ablation group had the highest complete ablation rate and the lowest recurrence compared with the other two groups (P<0.05). Conclusion: 55℃× 3 min microwave ablation is feasible and effective for Hepa1-6 cells subcutaneously implanted model of liver cancer in mice.

    Reference
    Related
    Cited by
Get Citation

WU Hao, SHEN Shunli, KUANG Ming, PENG Baogang. Thermal ablation for subcutaneously implanted hepatocellular carcinoma in mice[J]. Chin J Gen Surg,2012,21(8):973-977.
DOI:10.7659/j. issn.1005-6947.2012.08.014

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:February 16,2012
  • Revised:July 05,2012
  • Adopted:
  • Online: August 15,2012
  • Published: